Macrophages and CD4+ T lymphocytes from two multiply exposed, uninfected individuals resist infection with primary non-syncytium-inducing isolates of human immunodeficiency virus type 1

Journal of Virology

Volumn 70, Issue 12, 1996, Pages 8758-8764

  Connor, Ruth I ^a,b   Paxton, William A ^a   Sheridan, Kristine E ^a   Koup, Richard A ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b AARON DIAMOND AIDS RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ARTICLE; CELL TYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; MACROPHAGE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; T LYMPHOCYTE; VIRUS ISOLATION; VIRUS REPLICATION;

EID: 0029985197     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.12.8758-8764.1996     Document Type: Article

References (29)

1. Bhattacharyya, D., B. R. Brooks, and L. Callahan. 1996. Positioning of positively charged residues in the V3 loop correlates with HIV type 1 syncytium-inducing phenotype. AIDS Res. Hum. Retroviruses 12:83-90.
2. Chen, B. K., K. Saksela, R. Andino, and D. Baltimore. 1994. Distinct modes of human immunodeficiency type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses. J. Virol. 68:654-660.
3. Cheng-Mayer, C., D. Seto, M. Tateno, and J. A. Levy. 1988 Biologic features of HIV-1 that correlate with virulence in the host. Science 240:80-82.
4. + T cells. Science 270:1811-1815.
5. Combadiere, C., S. K. Ahuja, J. Van Damme, H. L. Tiffany, J.-L. Gao, and P. M. Murphy. 1995. Monocyte chemoattractant protein-3 is a functional ligand for C-C chemokine receptors I and 2B. J. Biol. Chem. 270:29671-29675.
6. Connor, R. I., B. K. Chen, S. Choc, and N. R. Landau. 1995. Vpr is required for efficient replication of human immunodeficiency virus type 1 in mononuclear phagocytes. Virology 206:935-944.
7. Connor, R. I., and D. D. Ho. 1994. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol. 68:4400-4408.
8. + T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J. Virol. 67:1772-1778.
9. Cornelissen, M., G. Mulder-Kampigna, J. Veenstra, F. Zorgdrager, C. Kuiken, S. Hartman, J. Dekker, L. van der Hoek, C. Sol, R. Coutinho, and J. Goudsmit. 1995. Syncytium-inducing (SI) phenotype suppression at sero-conversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population. J. Virol. 69:1810-1818.
10. de Jong, J.-J., J. Goudsmit, W. Keulen, B. Klaver, W. Krone, M. Tersmette, and A. de Ronde. 1992. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J. Virol. 66:757-765.
11. Delwart, E., E. G. Shpaer, J. Louwagie, F. E. McCutchan, M. Grez, H. Rubsamen-Waigmann, and J. I. Mullins. 1993. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science 262:1257-1261.
12. Deng, H. K., S. Choe, W. Ellmeier, R. Liu, D. Unutmaz, M. Burkhart, P. DiMarzio, S. Marmon, R. E. Sutton, C. M. Hill, C. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of C-C chemokine receptor 5 as the major coreceptor for entry of macrophage-tropic human immunodeficiency virus type-1. Nature (London) 381:661-666.
13. Detels, R., Z. Liu, K. Henessey, J. Kan, B. R Visscher, J. M. G. Taylor, D. R. Hoover, C. R Rinaldo, J. P. Phair, A. J. Saah, and J. V. Giorgi. 1994. Resistance to HIV-1 infection. J. Acquired Immune Defic. Syndr. 7:1263-1269.
14. Dragic, T., V. Litwin, G. P. Allaway, S. Martin, Y. Huang, K. A. Nagashima, C. Cayanan, P. J. Maddon, J. P. Moore, R. A. Koup, and W. A. Paxlon. 1996. β-chemokines inhibit HIV-1 entry into CD4+ cells via the C-C CKR5 co-receptor. Nature (London) 381:667-673.
15. Dulbecco, R. 1988. End-point method-measurement of the infectious titer of a viral sample, p. 22-23. In R. Dulbecco and H. S. Ginsberg (ed.), Virology, 2nd ed. J. B. Lippincott, Philadelphia.
16. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877.
17. Fenyö, E., L. Morfeldt-Måson, F. Chiodi, B. Lind, A. Von Gegerfeld, J. Albert, E. Olausson, and B. Åsjö. 1988. Distinctive replicative and cytopathic characteristics of human immunodeficiency virus isolates. J. Virol. 62:4414-4419.
18. Fouchier, R. A. M., M. Groenink, N. A. Kootstra, M. Tersmette, H. G. Huisman, F. Miedema, and H. Schuitemaker. 1992. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol. 66:3183-3187.
19. Gartner, S., P. Markovits, D. M. Markovitz, M. H. Kaplan, R C. Gallo, and M. Popovic. 1986. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233:215-219.
20. Koot, M., A. H. V. Vos, R. P. M. Keet, R. E. Y. DeGoede, M. W. Dercksen, F. G. Terpstra, R. A. Coutinho, F. Miedema, and M. Tersmette. 1992. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 6:49-54.
21. Koyanagi, Y., S. Miles, R. T. Mitsuyasu, J. E. Merrill, V. H. Vinters, and I. S. Y. Chen. 1987. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819-822.
22. Paxton, W. A., S. R. Martin, D. Tse, T. R. O'Brien, J. Skurnick, N. L. VanDevanter, N. Padian, J. F. Braun, D. P. Kotler, S. M. Wolinsky, and R. A. Koup. 1996. Relative resistance of HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nature Med. 2:412-417.
23. Roos, M. T. L., J. M. A. Lange, R. E. Y. de Goede, R. A. Coutinho, P. T. A. Schellekens, F. Miedema, and M. Tersmette. 1992. Viral phenotype and immune response in primary human immunodeficiency \irus type 1 infection. J. Infect. Dis. 165:427-432.
24. Schuitemaker, H., M. Koot, N. A. Kootsra, M. Wouter Dercksen, R. E. Y. de Goede, R. P. van Steenwijk, J. M. A. Lange, J. K. M. Eeftink Schattenkerk, F. Miedema, and M. Tersmette. 1992. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol. 66:1354-1360.
25. Spira, A. I., P. A. Marx, B. K. Patterson, R. A. Koup, S. M. Wolinsky, and D. D. Ho. 1996. Cellular targets of infection and route of viral dissemination following an intravaginal inoculation of SIV into rhesus macaques. J. Exp. Med. 183:215-225.
26. Stamatatos, L., and C. Cheng-Mayer. 1993. Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity, host range, and syncytium formation. J. Virol. 67:5635-5639.
27. Tersmette, M., R. E. Y. de Goede, B. J. M. AL, I. N. Winkel, R. A. Gruters, H. T. Cuypers, H. G. Huisman, and F. Miedema. 1988. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. 62:2026-2032.
28. Willey, R. L., T. S. Theodore, and M. A. Martin. 1994. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope. J. Virol. 68:4409-4419.
29. Zhu, T., H. Mo, N. Wang, D. S. Nam, Y. Cao, R. A. Koup, and D. D. Ho. 1993. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261:1179-1181.